Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1(R)-(1-(4-FLUOROPHENYL)-6-((1-METHYL-1H-PYRAZOL-4-1件: Pyrazole---1件: 75
2(R)-(1-(4-FLUOROPHENYL)-6-((1-METHYL-1H-PYRAZOL-4-YL)SULFONYL)-4,4A,5,6,7,8-HEXAHYDRO-1H-PYRAZOLO[3,4-G]ISOQUINOLIN-4A-YL)(4-(TRIFLUOROMETHYL)PYRIDIN-2-YL)METHANONE1件: Pyrazole---1件: 75
3(R)-(1-(4-FLUOROPHENYL)-6-((1-METHYL-1H-PYRAZOL-4-YL)SULFONYL)4,4A,5,6,7,8-HEXAHYDRO-1H-PYRAZOLO[3,4-G]ISOQUINOLIN-4A-YL)(4(TRIFLUOROMETHYL)PYRIDIN-2-YL)METHANONE1件: Pyrazole---1件: 75
417beta-hydroxy-11beta-(4-dimethylaminophenyl)17a-(prop-1-ynyl)estra-4,9-dien-3-one----1件: 75
517ß-hydroxy-11ß-(4-dimethylaminophenyl)17a-(prop-1-ynyl)estra-4,9-dien-3-one----1件: 75
618F-DOPA----2件: 6, 75
71H-Pyrazol1件: Pyrazole---5件: 2, 28, 46, 75, 154
82S,4R-(-)-ketoconazole1件: Ketoconazole1件: D00351 1件: CYP17A1 💬6件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬1件: 75
92S,4R-(-)-ketoconazole, levoketoconazole2件: Ketoconazole,
Levoketoconazole		2件: D00351 ,
D10950 		1件: CYP17A1 💬6件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬1件: 75
1068Ga-DOTATATE2件: Dotatate,
Dotatate gallium Ga-68		---3件: 75, 84, 238
11Abiraterone1件: Abiraterone---2件: 75, 81
12Abiraterone Acetate2件: Abiraterone,
Acetate		---2件: 75, 81
13Abiraterone acetato1件: Abiraterone---1件: 75
14Acetate1件: Acetate---43件: 1, 2, 6, 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299
15Acthrel1件: Corticorelin ovine triflutate1件: D03592 2件: CRHR1,
CRHR2 💬		4件: Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
16Alprazolam1件: Alprazolam1件: D00225 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬2件: 8, 75
17ATR-101----2件: 75, 81
18AZD4017----1件: 75
19AZD4017 and prednisolone1件: Prednisolone8件: D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 75
20Bexarotene1件: Bexarotene1件: D03106 3件: RXRA,
RXRB,
RXRG 💬		17件: Adipocytokine signaling pathway, Bile secretion, Chemical carcinogenesis - receptor activation, Gastric cancer, Hepatitis C, Lipid and atherosclerosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬2件: 13, 75
21CABERGOLINA1件: Cabergoline1件: D00987 2件: DRD2,
PRL 💬		12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬2件: 6, 75
22Cabergoline1件: Cabergoline1件: D00987 2件: DRD2,
PRL 💬		12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬3件: 6, 74, 75
23CABERGOLINE TEVA1件: Cabergoline1件: D00987 2件: DRD2,
PRL 💬		12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 75
24Calcium1件: Calcium---30件: 3, 6, 13, 15, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 256, 265, 274, 298, 299
25Calcium carbonate3件: Calcium,
Calcium carbonate,
Carbonate ion		2件: D00932 ,
D10802 		--8件: 13, 19, 46, 53, 75, 96, 235, 299
26Carbonate1件: Carbonate ion---12件: 2, 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299
27CHOLECALCIFEROL1件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬10件: 13, 19, 34, 46, 49, 75, 96, 97, 298, 299
28Cholecalciferol 15000 UNT/ML Oral Solution1件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 75
29CI-984----1件: 75
30CIALIS - 20 MG 2 COMPRESSE RIVESTITE CON FILM IN BLISTER USO ORALE1件: Tadalafil1件: D02008 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 75
31Continuous glucose monitoring1件: Dextrose, unspecified form---2件: 75, 299
32COR-003----1件: 75
33CORT1251341件: Relacorilant1件: D11336 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 75
34Corticotropin1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬9件: 2, 13, 46, 75, 78, 81, 84, 205, 222
35Corticotropin-releasing hormone2件: Corticorelin,
Corticotropin		2件: D00146 ,
D03905 		3件: CRHR1,
CRHR2,
MC2R 💬		6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 75, 205
36Cushing's syndrome confirmation----1件: 75
37Cyclo ((diaminoethyl-carbamate)HyPro-Phg-(D) Trp-Ly di-aspartate1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
38Cyclo ((diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Ly di-aspartate1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
39Cyclo((diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Lys-Tyr(Bzl)-Phe) di-aspartate1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
40Cyclo(diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Lys-Tyr(Bzl)-Phe)1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
41DDAVP1件: Desmopressin2件: D00291 ,
D02235 		2件: AVPR2,
F8 💬		4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬2件: 75, 288
42Dexamethasone1件: Dexamethasone9件: D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299
43Diagnostic Test: 24-hour Urine test----1件: 75
44Diagnostic Test: Blood test----1件: 75
45Diagnostic Test: Dexamethasone test1件: Dexamethasone9件: D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 75
46Diagnostic Test: Gated MRI scan----1件: 75
47Diagnostic Test: Routine MRI scan----1件: 75
48Diagnostic Test: Saliva swab----1件: 75
49DOSTINEX1件: Cabergoline1件: D00987 2件: DRD2,
PRL 💬		12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 75
50Dotatate1件: Dotatate---4件: 41, 75, 84, 238
51Eplerenone1件: Eplerenone1件: D01115 1件: NR3C2 💬1件: Aldosterone-regulated sodium reabsorption 💬4件: 75, 113, 210, 215
52G02CB03----1件: 75
53Gefitinib1件: Gefitinib1件: D01977 1件: EGFR 💬48件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis 💬1件: 75
54Genotropin 12mg1件: Somatotropin1件: D02691 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬3件: 74, 75, 78
55Genotropin 5.3mg1件: Somatotropin1件: D02691 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬3件: 74, 75, 78
56Genotropin Miniqu1件: Somatotropin1件: D02691 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬3件: 74, 75, 78
57Genotropin Miniquick 0.2mg1件: Somatotropin1件: D02691 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬3件: 74, 75, 78
58Genotropin Miniquick 0.4mg1件: Somatotropin1件: D02691 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬3件: 74, 75, 78
59Genotropin Miniquick 0.6mg1件: Somatotropin1件: D02691 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬3件: 74, 75, 78
60Genotropin Miniquick 0.8mg1件: Somatotropin1件: D02691 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬3件: 74, 75, 78
61Genotropin Miniquick 1.0mg1件: Somatotropin1件: D02691 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬3件: 74, 75, 78
62Genotropin Miniquick 1.2mg1件: Somatotropin1件: D02691 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬3件: 74, 75, 78
63Glucocorticoids----8件: 40, 41, 43, 44, 60, 62, 75, 300
64Glucophage (metformin)1件: Metformin2件: D00944 ,
D04966 		2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬2件: 46, 75
65Glucose1件: Dextrose, unspecified form---15件: 2, 6, 13, 49, 50, 65, 75, 86, 88, 96, 160, 195, 254, 257, 299
66HRA052015----1件: 75
67HRA052015 (mifepristone)1件: Mifepristone1件: D00585 2件: NR3C1,
PGR 💬		6件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Neuroactive ligand-receptor interaction, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 75
68Hydrocortisone1件: Hydrocortisone1件: D00088 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬10件: 6, 41, 46, 53, 75, 78, 81, 83, 97, 299
69Hypercortisolism----1件: 75
70Hypro----1件: 75
71Insulin----6件: 6, 13, 46, 75, 78, 299
72IPC----1件: 75
73Ketoconazole1件: Ketoconazole1件: D00351 1件: CYP17A1 💬6件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬3件: 8, 13, 75
74L0006CP03A----1件: 75
75L01XX14----1件: 75
76LA----5件: 6, 13, 75, 76, 222
77Lapatinib1件: Lapatinib2件: D04024 ,
D08108 		2件: EGFR,
ERBB2 💬		50件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Platinum drug resistance, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Tight junction 💬3件: 34, 74, 75
78Lateral transperitoneal LA----1件: 75
79LCI699----1件: 75
80LCI699, 1 mg----1件: 75
81LCI699, 10 mg----1件: 75
82LCI699, 20 mg----1件: 75
83LCI699, 5 mg----1件: 75
84Levoketoconazole1件: Levoketoconazole1件: D10950 --1件: 75
85Levoketozonazole----1件: 75
86Liqourice----1件: 75
87Liraglutide1件: Liraglutide1件: D06404 1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬3件: 6, 75, 193
88LMWH/Rivaroxaban1件: Rivaroxaban1件: D07086 1件: F10 💬1件: Complement and coagulation cascades 💬1件: 75
89Matyrapone----1件: 75
90Metformin1件: Metformin2件: D00944 ,
D04966 		2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬24件: 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301
91Methionine1件: Methionine2件: D00019 ,
D04983 		--7件: 34, 75, 84, 93, 229, 298, 300
92Metopirone1件: Metyrapone2件: D00410 ,
D05019 		1件: CYP11B1 💬4件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬1件: 75
93Metopirone 250 mg capsules1件: Metyrapone2件: D00410 ,
D05019 		1件: CYP11B1 💬4件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬1件: 75
94Metopirone 250 mg capsules/ Cormeto1件: Metyrapone2件: D00410 ,
D05019 		1件: CYP11B1 💬4件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬1件: 75
95Metopirone 250 mg capsules/Cormeto1件: Metyrapone2件: D00410 ,
D05019 		1件: CYP11B1 💬4件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬1件: 75
96METYRAPONE1件: Metyrapone2件: D00410 ,
D05019 		1件: CYP11B1 💬4件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬2件: 75, 193
97Mifedren----1件: 75
98MIFEPRISTONE1件: Mifepristone1件: D00585 2件: NR3C1,
PGR 💬		6件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Neuroactive ligand-receptor interaction, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 75
99Nevanimibe1件: Nevanimibe1件: D11300 --2件: 75, 81
100Nevanimibe hydrochloride1件: Nevanimibe1件: D11300 --2件: 75, 81
101NIZORAL1件: Ketoconazole1件: D00351 1件: CYP17A1 💬6件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬1件: 75
102NON COMMERCIAL----1件: 75
103Octreotide1件: Octreotide2件: D00442 ,
D06495 		1件: SSTR2 💬4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬7件: 67, 75, 84, 85, 89, 193, 227
104OROCAL----1件: 75
105OSILODROSTAT1件: Osilodrostat1件: D11061 1件: CYP11B2 💬3件: Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis 💬1件: 75
106Osilodrostat 10mg1件: Osilodrostat1件: D11061 1件: CYP11B2 💬3件: Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis 💬1件: 75
107Osilodrostat 1mg1件: Osilodrostat1件: D11061 1件: CYP11B2 💬3件: Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis 💬1件: 75
108Osilodrostat 20mg1件: Osilodrostat1件: D11061 1件: CYP11B2 💬3件: Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis 💬1件: 75
109Osilodrostat 5mg1件: Osilodrostat1件: D11061 1件: CYP11B2 💬3件: Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis 💬1件: 75
110Ossein hydroxyapatite----1件: 75
111OSTEOPOR----1件: 75
112Other: [11C]-Methionine PET/MRI1件: Methionine2件: D00019 ,
D04983 		--1件: 75
113Other: Control----9件: 6, 19, 67, 70, 75, 85, 97, 162, 193
114Other: Hydrocortisone1件: Hydrocortisone1件: D00088 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 75
115Other: Obese----1件: 75
116Ovine Corticotropin-Releasing Hormone (oCRH)2件: Corticorelin,
Corticotropin		2件: D00146 ,
D03905 		3件: CRHR1,
CRHR2,
MC2R 💬		6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
117Pasireotida1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
118Pasireotida 3001件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
119Pasireotida 6001件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
120Pasireotida 9001件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
121Pasireotide1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬3件: 67, 74, 75
122Pasireotide 0.3mg1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
123Pasireotide 0.6 MG/ML1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
124Pasireotide 0.6mg1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
125Pasireotide 0.9 mg1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
126Pasireotide 20mg1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
127Pasireotide 40mg1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
128Pasireotide 60mg1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
129PASIREOTIDE DIASPARTATE1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
130Pasireotide LAR1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 67, 75
131PASIREOTIDE PAMOATE1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
132Pasireotide s.c.1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
133Pasireotide sub-cutaneous1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
134Pasireotide with or without cabergoline2件: Cabergoline,
Pasireotide		2件: D00987 ,
D10147 		6件: DRD2,
PRL,
SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 75
135Pasireotode----1件: 75
136Pentetreotide1件: Pentetreotide1件: D01859 --1件: 75
137Phe----2件: 75, 240
138Posterior RA----1件: 75
139PREDNISOLONE1件: Prednisolone8件: D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬43件: 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307
140R-roscovitine1件: Seliciclib---1件: 75
141Radiation: CT scan----1件: 75
142Radiation: DOTATATE PET-CT1件: Dotatate---1件: 75
143Radiation: F-DOPA PET CT----1件: 75
144Relacorilant1件: Relacorilant1件: D11336 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 75
145Rivaroxaban1件: Rivaroxaban1件: D07086 1件: F10 💬1件: Complement and coagulation cascades 💬5件: 46, 49, 75, 91, 210
146Rosiglitazone1件: Rosiglitazone2件: D00596 ,
D08491 		1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬5件: 46, 75, 97, 222, 265
147Rosiglitazone maleate1件: Rosiglitazone2件: D00596 ,
D08491 		1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬3件: 46, 75, 265
148RVG 08938----1件: 75
149RVG 15375----1件: 75
150RVG 18236----2件: 75, 227
151Seliciclib1件: Seliciclib---2件: 75, 299
152SIGNIFOR1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
153Silycus----1件: 75
154Sitagliptin1件: Sitagliptin1件: D08516 1件: DPP4 💬1件: Protein digestion and absorption 💬4件: 6, 75, 233, 299
155SOM230----2件: 74, 75
156SOM230 300µg----1件: 75
157SOM230 600µg----1件: 75
158SOM230 900µg----1件: 75
159SOM230 LAR----1件: 75
160SOM230 LAR 10 mg----1件: 75
161SOM230 LAR 30 mg----1件: 75
162SOM230 LAR, 20 mg----1件: 75
163SOM230 s.c.----1件: 75
164SOM230, 300micrograms----1件: 75
165SOM230, 600 micrograms----1件: 75
166SOM230, 900 micrograms----1件: 75
167SOM230B----1件: 75
168Somatropin1件: Somatotropin1件: D02691 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬19件: 2, 3, 19, 46, 65, 74, 75, 78, 96, 107, 113, 187, 193, 195, 238, 265, 274, 276, 299
169Tadalafil1件: Tadalafil1件: D02008 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬7件: 6, 51, 75, 84, 86, 113, 210
170Tretinoin1件: Tretinoin1件: D00094 3件: PML,
RARA,
RARB 💬		12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬3件: 2, 62, 75
171TRETINOINA1件: Tretinoin1件: D00094 3件: PML,
RARA,
RARB 💬		12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬1件: 75
172Trp----1件: 75
173Tyr----2件: 75, 298
174Valsartan1件: Valsartan1件: D00400 1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬7件: 57, 58, 66, 75, 218, 222, 224
175VESANOID1件: Tretinoin1件: D00094 3件: PML,
RARA,
RARB 💬		12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬1件: 75
176Vorinostat1件: Vorinostat1件: D06320 11件: HDAC1,
HDAC10,
HDAC11,
HDAC2,
HDAC3,
HDAC4,
HDAC5,
HDAC6,
HDAC7,
HDAC8,
HDAC9 💬		17件: Alcoholism, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Cell cycle, Chronic myeloid leukemia, Epstein-Barr virus infection, Human papillomavirus infection, Huntington disease, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, Notch signaling pathway, Pathways in cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Viral carcinogenesis 💬3件: 19, 75, 96
177ZYTIGA1件: Abiraterone---1件: 75
178ZYTIGA - 250 MG - COMPRESSA - USO ORALE - FLACONE 120 COMPRESSE1件: Abiraterone---1件: 75